Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
SYNB1891 is a non-pathogenic strain of Escherichia coli that express STING (TMEM173), in order to stimulate the anti-tumor response of the innate immune system (NCI Drug Dictionary).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Atezolizumab + SYNB1891||Atezolizumab SYNB1891||0||1|